Trials / Completed
CompletedNCT03440814
A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- Soleno Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this is study is to evaluate the effects of DCCR (diazoxide choline controlled release tablets) in children and adults with Prader-Willi syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DCCR | Once daily oral administration |
| DRUG | Placebo for DCCR | Once daily oral administration |
Timeline
- Start date
- 2018-05-09
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2018-02-22
- Last updated
- 2023-09-21
- Results posted
- 2023-09-21
Locations
29 sites across 2 countries: United States, United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03440814. Inclusion in this directory is not an endorsement.